Ingredient or product comparison
Can You Stack GHK-Cu Cosmetic Other Peptides: Mechanism Comparison
This table compares the primary mechanisms, receptor targets, and clinical endpoints of peptides commonly stacked with GHK-Cu to demonstrate how mechanistic diversity drives synergistic outcomes. GHK-Cu Copper-mediated MMP modulation, TGF-beta 1 signaling Meta
This source-based comparison does not add ratings or recommend a winner.
- This table compares the primary mechanisms, receptor targets, and clinical endpoints of peptides commonly stacked with GHK-Cu to demonstrate how mechanistic diversity drives synergistic outcomes.
- GHK-Cu
- Copper-mediated MMP modulation, TGF-beta 1 signaling
- Metalloproteinases, TGF-beta receptors
- Increases type I collagen synthesis by ~70%, reduces MMP-1 by ~50%
- Reduces TNF-alpha 30–40%
- 2–4 hours topical
- Gold standard for direct collagen stimulation. Anchor peptide in most stacks
- BPC-157
- VEGF upregulation, nitric oxide pathway activation
- VEGF receptors, eNOS pathway
- Indirect. Enhances vascularization to collagen-producing cells
- Reduces IL-6, promotes angiogenesis
- ~4 hours systemic
- Best stacking partner for vascular support. Complements GHK-Cu without mechanism overlap
- TB-500
- Actin monomer binding, cell migration facilitation
- Actin cytoskeleton, NFκB pathway
- Minimal direct effect. Supports fibroblast migration to synthesis sites
- Downregulates NFκB signaling
- 7–10 days systemic
- Ideal for migration and inflammation. Longest half-life allows twice-weekly dosing
- Matrixyl (Palmitoyl Pentapeptide)
- TGF-beta receptor II activation, ECM gene expression
- TGF-beta receptor II
- Increases type I/III collagen, fibronectin production
- Minimal anti-inflammatory action
- 6–8 hours topical
- Synergistic with GHK-Cu due to different TGF-beta receptor subtype targeting
- KPV Tripeptide
- Melanocortin receptor agonism, immune modulation
- MC1R, MC3R receptors
- No direct collagen effect
- Potent anti-inflammatory via MC receptor pathways
- 2–3 hours topical
- Stack for inflammation control. Mechanistically distinct from GHK-Cu's copper pathway